Latest Content

Edward Choy, partner at Sho Eyeworks, and Diana Canto-Sims, OD, discuss the company's price points and partner subscription options.

New drugs on the market and survey findings were among some of the top stories in dry eye from the past year.

Understanding the different expectations between patients with these conditions is key to choosing the appropriate refractive surgery.

An overview of the top 10 stories from eye care for 2025.

The researchers conducted a literature search of MEDLINE and Embase, PubMed, Cochrane Library, and Web of Sciences databases from 2003 to 2023.

Edward Choy, partner at Sho Eyeworks, and Diana Canto-Sims, OD, drive home the importance of profitability in creating an eyewear brand.

The PDUFA target action date is June 30, 2026.

Justin Schweitzer, OD, outlines the intricacies of glaucoma care with 3 cases.

The study evaluated thermal dynamics associated with CW-TSCPC and TLT using MicroPulse technology, such as temperature peak, exposure duration, and thermal spread in a simulated ciliary body using computer modeling.

NCX 470 is Nicox’s lead dual-mechanism bimatoprost eye drop for lowering IOP in open-angle glaucoma or ocular hypertension.

RGCs can offer a window into confirming eye condition diagnoses.

K8 is a member of a new class of inflammasome-inhibiting drugs called kamuvudines.

Isocyclosporin is a dual inhibitor of transient receptor potential cation channel, mucolipin subfamily, member 2 (TRPML2), and calcineurin.